CASP3 and metabolic dysfunction-associated steatotic liver disease: Similar to previous reports, we also found that expression levels of CHOP, C-calnexin, and C-caspase-3 were efficiently decreased by BME, whereas BiP expression level was slightly increased in PA-treated HepG2 cells and animal model of NAFLD.